Literature DB >> 15714424

Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.

Didier Neau1, Maria Winnock, Anne-Christine Jouvencel, Murielle Faure, Laurent Castéra, Elisabeth Legrand, Denis Lacoste, Jean-Marie Ragnaud, Michel Dupon, Hervé Fleury, Marie-Edith Lafon, François Dabis.   

Abstract

We prospectively assessed the prevalence of occult hepatitis B virus (HBV) infection by investigating HBV replication in 160 human immunodeficiency virus (HIV)-infected patients with isolated antibodies to hepatitis B core antigen. This prevalence was 0.6% (1 case/160 patients; 95% confidence interval, 0%-3.4%). A second serum sample was collected later from 52 of the patients. HBV DNA was once again undetectable in all patients, except for the sole patient who had previously been found to be HBV DNA positive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714424     DOI: 10.1086/427882

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

Review 1.  Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.

Authors:  Angelica Maldonado-Rodriguez; Ana Maria Cevallos; Othon Rojas-Montes; Karina Enriquez-Navarro; Ma Teresa Alvarez-Muñoz; Rosalia Lira
Journal:  World J Hepatol       Date:  2015-02-27

2.  Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.

Authors:  Audrey L French; Anna Hotton; Mary Young; Marek Nowicki; Michael Augenbraun; Kathryn Anastos; Eric Seaberg; William Rosenberg; Marion G Peters
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

Review 3.  Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.

Authors:  Jennifer J Chang; Neaka Mohtashemi; Debika Bhattacharya
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

4.  Occult hepatitis B infection in the immigrant population of Sicily, Italy.

Authors:  Fabio Tramuto; Carmelo M Maida; Giuseppina M E Colomba; Paola Di Carlo; Giovanni Mazzola; Valentina Li Vecchi; Mario Affronti; Giuseppe Montalto; Francesco Vitale
Journal:  J Immigr Minor Health       Date:  2013-08

5.  Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.

Authors:  G Morsica; F Ancarani; S Bagaglio; M Maracci; P Cicconi; A Cozzi Lepri; G Antonucci; R Bruno; T Santantonio; L Tacconi; F Baldelli; R Piscopo; D Santoro; A Lazzarin; A D'Arminio Monforte
Journal:  Infection       Date:  2009-08-07       Impact factor: 3.553

Review 6.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

7.  Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.

Authors:  Stefan Reuter; Mark Oette; Frank Clemens Wilhelm; Bastian Beggel; Rolf Kaiser; Melanie Balduin; Finja Schweitzer; Jens Verheyen; Ortwin Adams; Thomas Lengauer; Gerd Fätkenheuer; Herbert Pfister; Dieter Häussinger
Journal:  Med Microbiol Immunol       Date:  2010-09-19       Impact factor: 3.402

8.  Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.

Authors:  Judith I Tsui; Audrey L French; Eric C Seaberg; Michael Augenbraun; Marek Nowicki; Marion Peters; Phyllis C Tien
Journal:  Clin Infect Dis       Date:  2007-08-10       Impact factor: 9.079

9.  Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients.

Authors:  Ma Teresa Pérez-Rodríguez; Bernardo Sopeña; Manuel Crespo; Alberto Rivera; Teresa González del Blanco; Antonio Ocampo; César Martínez-Vázquez
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 10.  Clinical impact of occult hepatitis B virus infection in immunosuppressed patients.

Authors:  Evangelista Sagnelli; Mariantonietta Pisaturo; Salvatore Martini; Pietro Filippini; Caterina Sagnelli; Nicola Coppola
Journal:  World J Hepatol       Date:  2014-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.